10pc growth for Siemens Medical Solutions

DUBAI — Siemens Medical Solutions has posted an impressive 10 per cent growth across the Middle East and North Africa (Mena).

By A Staff Reporter

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Sat 12 Feb 2005, 9:12 AM

Last updated: Thu 2 Apr 2015, 7:29 PM

The expansion in Mena, excluding Iraq, has been spurred by a series of device innovations that have transformed the company into one of the world’s largest suppliers to the global health care industry.

Maurice Faber, Head of Siemens Medical Solutions, said the increase in regional sales reflects Siemens Medical Solutions’ ambition to become the most successful solution provider for the health care sector worldwide.

“For this purpose, we provide our customers in the Mena region with tailor-made solutions for their medical and business-related requirements that provide them with proven clinical or financial outcomes, in short a better quality of health care at reduced costs,” Faber said.

The regional rise in sales follows the eight per cent rise in overall sales for the group to EUR 7.42 billion, as reported by Siemens Medical Solutions in fiscal year 2003/04. Among the 16 different subsidiaries of the parent company, Siemens AG, Siemens Medical Solutions is one of the most profitable and employs approximately 31,000 people worldwide at several manufacturing sites in Europe, the US and Asia.

The rise in revenue is also symptomatic of Siemens’ “Proven Outcomes” concept, which includes increased patient throughput, more efficient processes with the help of performance-oriented software and database architecture, error reductions and a boost in patient, physician and staff satisfaction.

“Two thirds of all Siemens Medical Solutions’ products are under three years old. Currently, the division is filing an average of three patent applications per work day. So we are seen as an highly-innovative, dynamic force in global health care. This has not gone unnoticed in the Middle East, as our financial results demonstrate,” Faber added.

More news from